Search results
Results from the WOW.Com Content Network
Fuchs spots are caused by regression of choroidal neovascularization. [3] Since it is a medical sign, treatment is given for the actual cause. Photothermal laser ablation, photodynamic therapy, anti-VEGF therapy, or a combination of these are the treatment options of choroidal neovascularization due to pathological myopia.
Nyctalopia (/ ˌ n ɪ k t ə ˈ l oʊ p i ə /; from Ancient Greek νύκτ-(núkt-) ' night ' ἀλαός (alaós) ' blind, invisible ' and ὄψ (óps) ' eye '), [1] also called night blindness, is a condition making it difficult or impossible to see in relatively low light.
Many myopia treatment studies have a number of design drawbacks: small numbers, lack of adequate control group, and failure to mask examiners from knowledge of treatments used. The best approach is to combine multiple prevention and control methods. [ 97 ]
In many cases, myopia will stabilize once the growth process has been completed, but in more severe chronic cases, loss of vision can occur. Degenerative myopia, also known as malignant, pathological, or progressive myopia, is characterized by posterior sclera elongation and thinning (at least 25.5 mm to 26.5 mm) and high refractive errors of ...
In myopia that is no longer progressing, the crescent may be asymptomatic except for its presence on ocular examination. However, in high-degree myopia, it may extend to the upper and lower borders, or form a complete ring around the optic disc and form a central scotoma. The myopic crescent is commonly seen in pathological axial myopia.
Multifocal choroiditis occurs mainly in myopic females. The fundus presents with yellow or gray lesions (white dots) at the level of the choroid and retinal pigment epithelium. The size of the white dots are between 50 and 500 micrometres and localized in the macula. The disease is characterized by vitritis and anterior chamber inflammation.
This is a partial list of human eye diseases and disorders. The World Health Organization (WHO) publishes a classification of known diseases and injuries, the International Statistical Classification of Diseases and Related Health Problems , or ICD-10.
Rivaroxaban had a high number of reports of retinal and vitreous hemorrhage despite the fact that it was approved by the Food and Drug Administration a year later than dabigatran, suggesting a higher risk in patients taking rivaroxaban than patients taking dabigatran. Apixaban had the least association with either condition.